糖尿病非药物预防计划的成本效益:基于试验的研究的系统审查
Yongyi Xiong1, Zhaohua Huo1, Samuel Y S Wong1
1Jockey Club School of Public Health and Primary Care, Prince of Wales Hospital The Chinese University of Hong Kong Shatin Hong Kong China.
Chronic diseases and translational medicine
|March 7, 2024
概括
非药物干预有效地预防2型糖尿病 (T2DM). 生活方式干预措施,特别是非DPP的干预措施,比对高风险个体的教育方法更具成本效益.
科学领域:
- 卫生经济学 卫生经济学
- 预防医学 预防医学
- 公共卫生 公共卫生
背景情况:
- 糖尿病预防计划的经济价值尚未得到充分证实.
- 在高风险人群中,非药物干预对于预防2型糖尿病 (T2DM) 至关重要.
研究的目的:
- 审查预防高风险个体T2DM的非药物干预措施的成本效益.
- 综合各种干预类型和交付方法的经济证据.
主要方法:
- 在2022年3月之前对六个电子数据库进行系统审查.
- 包括评估非药物治疗T2DM预防干预措施的成本和健康结果的研究.
- 使用综合健康经济评估报告标准2022检查清单和叙事综合的质量评估.
主要成果:
- 与常规护理相比,生活方式干预比教育干预具有更高的成本效益.
- 不基于DPP的生活方式干预 (中位数ICER:1395美元/QALY) 比基于DPP的方案 (中位数ICER:2707美元/QALY) 更具成本效益.
- 同行支持或移动技术的非专业人士的联合交付方法和干预显示出潜在的成本效益,特别是在资源有限的环境中.
结论:
- 预防T2DM的非药物干预措施具有成本效益,在各种环境中都是可行的.
- 从低收入和中等收入国家需要进一步的经济证据.
- 使用受过培训的非专业人员,同行支持或移动技术的干预措施可能在资源有限的环境中提供具有成本效益的解决方案.
相关概念视频
Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282
Preventive Healthcare Services
1.0K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.0K
Levels of Health Promotion and Illness Prevention
12.6K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
12.6K
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Oral Hypoglycemic Agents: Biguanides and Glitazones
199
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
199


